Pediatric obsessive-compulsive disorder: management in primary care

Current Opinion in Pediatrics

Volumn 20, Issue 5, 2008, Pages 544-550

  Gilbert, Andrew R ^a   Maalouf, Fadi T ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Neuropsychiatry; Obsessive compulsive disorder; Pediatric; Pediatric autoimmune neuropsychiatrie disorder associated with streptococcal infections; Selective serotonin reuptake inhibitor; Therapy

Indexed keywords

ARIPIPRAZOLE; CLOMIPRAMINE; FLUOXETINE; FLUVOXAMINE; NEUROTRANSMITTER; PAROXETINE; PLACEBO; SERTRALINE;

ADOLESCENCE; AUTISM; CARDIOVASCULAR DISEASE; CHILDHOOD; CLINICAL FEATURE; CLINICAL RESEARCH; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG EFFICACY; EATING DISORDER; EMERGENCY HEALTH SERVICE; FAMILY DECISION MAKING; GENERALIZED ANXIETY DISORDER; GENETIC VARIABILITY; HUMAN; MAJOR DEPRESSION; MONITORING; NEUROPSYCHIATRY; OBSESSIVE COMPULSIVE DISORDER; PATHOPHYSIOLOGY; PATIENT REFERRAL; PEDIATRICS; PHYSICIAN; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW; SEIZURE; SIDE EFFECT; SYMPTOM; TIC; WEIGHT GAIN;

ADOLESCENT; AGE DISTRIBUTION; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; COMORBIDITY; FEMALE; HUMANS; MALE; MONITORING, PHYSIOLOGIC; OBSESSIVE-COMPULSIVE DISORDER; PREVALENCE; PRIMARY HEALTH CARE; PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; REFERRAL AND CONSULTATION; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; TREATMENT OUTCOME; UNITED STATES;

EID: 53549111893     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e32830f93d9     Document Type: Review

References (40)

1. Leonard HL, Ale CM, Freeman JB, et al. Obsessive-compulsive disorder. Child Adolesc Psychiatr Clin N Am 2005; 14:727-743.
2. Geller DA. Obsessive-compulsive and spectrum disorders in children and adolescents. Psychiatr Clin North Am 2006; 29:353-370.
3. Piacentini J, Bergman R, Keller M. Functional impairment in children and adolescents with obsessive-compulsive disorder. J Child Adolesc Psycho-Pharmacol 2003; 13:S61-S69.
4. Murray C, Lopez A. Global Burden of disease: a comprehensive assessment of mortality and morbidity from diseases, injuries and risk factors in 1990 and projected to 2020. Vol. 1. Cambridge: Harvard University Press; 1996.
5. Stewart SE, Geller DA, Jenike M, et al. Long-term outcome of pediatric obsessive-compulsive disorder: a meta-analysis and qualitative review of the literature. Acta Psychiatr Scand 2004; 110:4-13.
6. Swedo SE, Rapoport JL, Leonard H, et al. Obsessive-compulsive disorder in children and adolescents: clinical phenomenology of 70 consecutive cases. Arch Gen Psychiatry 1989; 46:335-341.
7. Allen AJ, Leonard HL, Swedo SE. Case study: a new infection-triggered, autoimmune subtype of pediatric OCD and Tourette's syndrome. J Am Acad Child Adolesc Psychiatry 1995; 34:307-311.
8. Murphy ML, Pichichero ME. Prospective identification and treatment of children with pediatric autoimmune neuropsychiatric disorder associated with group A streptococcal infection. Arch Pediatr Adolesc Med 2002; 156:356-361.
9. Snider LA, Lougee L, Slattery M, et al. Antibiotic prophylaxis with azithromycin or penicillin for childhood-onset neuropsychiatric disorders. Biol Psychiatry 2005; 57:788-792.
10. Arnold PD, Richter MA. Is obsessive-compulsive disorder an autoimmune disease? JAMC 2001; 165:1353-1358.
11. Mataix-Cols D, Rosario-Campos MR, Leckman JF. A multidimensional model of obsessive-compulsive disorder. Am J Psychiatry 2005; 162:228-238.
12. Rosario-Campos MC, Miguel EC, Quatrano S, et al. The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions. Mol Psychiatry 2006; 11:495-504.
13. Stewart SE, Rosario MC, Brown TA, et al. Principal components analysis of obsessive-compulsive disorder symptoms in children and adolescents. Biol Psychiatry 2007; 61:285-291.
14. Arnold PD. Sicard T, Burroughs E, et al. Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder. Arch Gen Psychiatry 2006; 63:769-776.
15. Hettema JM, Neale MC, Kendler KS. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 2001; 158:1568-1578.
16. Scahill L, Riddle M, McSwiggen-Hardin M, et al. Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry 1997; 36:844-852.
17. Uher R, Heyman I, Turner CM, Shafran R. Self, parent-report and interview measures of obsessive-compulsive disorder in children and adolescents. J Anxiety Disord 2008; 22:979-990.
18. Uher R, Heyman I, Mortimore C, et al. Screening young people for obsessive compulsive disorder. Br J Psychiatry 2007; 191:353-354.
19. Storch EA, Lack CW, Merlo LJ, et al. Clinical features of children and adolescents with obsessive-compulsive disorder and hoarding symptoms. Compr Psychiatry 2007; 48:313-318.
20. Masi G, Perugi G, Millepiedi S, et al. Bipolar co-morbidity in pediatric obsessive-compulsive disorder: clinical and treatment implications. J Child Adolesc Psychopharm 2007; 17:475-486.
21. Walitza S, Zellmann H, Irblich B, et al. Children and adolescents with obsessive-compulsive disorder and comorbid attention-deficit/hyperactivity disorder: preliminary results of a prospective follow-up study. J Neural Transm 2008; 115:187-190.
22. Geller D, Petty C, Vivas F, et al. Further evidence for co-segregation between pediatric obsessive compulsive disorder and attention deficit hyperactivity disorder: a familial risk analysis. Biol Psychiatry 2007; 61:1388-1394.
23. Ivarsson T, Melin K. Autism spectrum traits in children and adolescents with obsessive-compulsive disorder (OCD). J Anxiety Disord 2008; 22:969-978.
24. Stewart SE, Beresin C, Haddad S, et al. Predictors of family accommodation in obsessive-compulsive disorder. Ann Clin Psychiatry 2008; 20:65-70.
25. March JS, Mulle K. OCD in children and adolescents: a cognitive-behavioral treatment manual. New York: Guilford Press; 1998.
26. Wagner AP. What to do when your child has obsessive-compulsive disorder: strategies and solutions. Rochester: Lighthouse Press; 2002.
27. The Pediatric OCD Treatment Study (POTS) team. Cognitive-behavioral therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA 2004; 292:1969-1976.
28. O'Kearney RT, Anstey KJ, von Sanden C. Behavioral and cognitive behavioral therapy for obsessive compulsive disorder in children and adolescents [review]. Cochrane Database Syst Rev 2006:CD004856.
29. Freeman JB, Choate-Summer ML, Moore PS, et al. Cognitive behavioral treatment for young children with obsessive-compulsive disorder. Biol Psychiatry 2007; 61:337-343.
30. Bolton D, Perrin S. Evaluation of exposure with response-prevention for obsessive compulsive disorder in childhood and adolescence. J Behav Ther Exp Psychiatry 2008; 39:11-22.
31. Storch EA, Geffken GR, Merlo LJ, et al. Family-based cognitive behavioral therapy for pediatric obsessive-compulsive disorder: comparison of intensive and weekly approaches. J Am Acad Child Adolesc Psychiatry 2007; 46:469-478.
32. Storch EA, Murphy TK, Geffken GR, et al. Cognitive-behavioral therapy for PANDAS related obsessive-compulsive disorder: findings from a preliminary wait-list controlled open trial. J Am Acad Child Adolesc Psychiatry 2006; 45:1171-1178.
33. Bloch MH, Landeror-Weisenbereger A, Kelmendi B, et al. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder. Mol Psychiatry 2006; 11:622-632.
34. Storch EA, Lehmkuhl H, Geffken GR, et al. Aripiprazole augmentation of incomplete treatment response in an adolescent male with obsessive-compulsive disorder. Depress Anxiety 2008; 0:1-3.
35. Geller DA, Biederman J, Stewart SE, et al. Impact of comorbidity on treatment response to paroxetine in pediatric obsessive-compulsive disorder: is the use of exclusion criteria empirically supported in randomized clinical trials? J Child Adolesc Psychopharmacol 2003; 13:S19-S29.
36. Leonard HL, Swedo SE, Lenane MC, et al. A 2- to 7-year follow-up study of 54 obsessive-compulsive children and adolescents. Arch Gen Psychiatry 1993; 50:429-439.
37. March JS, Franklin ME, Leonard H, et al. Tics moderate treatment outcome with sertraline but not cognitive-behavioral therapy in pediatric obsessive-compulsive disorder. Biol Psychiatry 2007; 61:344-347.
38. Bridge JA, Iyengar S, Salary CB, et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA 2007; 297:1683-1696.
39. Reinblatt SP, Riddle MA. The pharmacological management of childhood anxiety disorders: a review. Psychopharmacology 2007; 191:67-86.
40. Pine DS. Treating children and adolescents with selective serotonin reuptake inhibitors: how long is appropriate? J Child Adolesc Psychopharmacol 2002; 12:189-203.